Longevity AI

Company Overview

Snapshot

Founded in September 2021 by Guy Leitersdorf, Longevity AI operates with 11–50 employees. The company has raised $5 million across two funding rounds.

Business overview

Longevity AI develops a clinical intelligence platform designed for proactive, preventive care. Its core technology unifies patient data from medical records, lifestyle applications, and third-party vendors, providing clinicians with a continuously updated view of each patient. The platform's clinical companion, Florence, synthesizes this data and generates personalized longevity plans, aiming to reduce the time clinicians spend on routine analysis by at least 50%. Longevity AI serves practices of all sizes, from annual physicals to concierge medicine, operating within the Digital Healthcare and Digital Therapeutics sectors.

Strategic signal

In July 2024, Longevity AI announced a big data research partnership with Clalit Health Services. This collaboration signals a strategic move to leverage real-world data from a major healthcare provider, validating the company's technology and its potential for broader adoption and impact in preventive care and chronic disease management.

Company Intelligence Q&A

What is Longevity AI's primary focus?

Longevity AI focuses on proactive, preventive care through its clinical intelligence platform, which unifies patient data to provide clinicians with comprehensive insights and personalized longevity plans.

Who founded Longevity AI and when?

Longevity AI was founded in September 2021 by Guy Leitersdorf.

What significant partnership did Longevity AI announce in 2024?

In July 2024, Longevity AI announced a big data research partnership with Clalit Health Services.

What is the total capital raised by Longevity AI?

Longevity AI has raised a total of $5 million across two funding rounds.